Replies to post #1428 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

As far as I can tell, the business units Cambrex is selling to Lonza do not include the unit that does the downstream processing for ATryn.

Here’s more on the story from the Lonza point of view: #msg-14248241.